Research & Development
Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio
20 May 2026 - Healthcare technology company Medtronic plc (NYSE: MDT) announced on Wednesday that it intends to acquire privately held SPR Therapeutics Inc for approximately USD650m in cash, expanding...
Implantica submits final FDA response for RefluxStop PMA application
20 May 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Wednesday that it has submitted its final response to the US Food and Drug Adm...
FDA approves MEKanistic Therapeutics' IND for MTX-531
20 May 2026 - Biotechnology company MEKanistic Therapeutics announced on Tuesday that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug application for MTX-531, its le...
Matter Bio submits first IND application for Lm-LLO-TT
20 May 2026 - Biotechnology company Matter Bio announced on Tuesday the submission of its first Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for Lm-LLO-TT fo...
Hansa Biopharma signs EUR115m IDEFIRIX licensing deal with SERB
19 May 2026 - Swedish biotechnology company Hansa Biopharma AB (STO:HNSA) announced on Tuesday an exclusive licensing agreement with specialty pharmaceutical company SERB S.A. for the development and ...
Lupin receives tentative FDA approval for Revefenacin Inhalation Solution
19 May 2026 - Global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Monday that it the US Food and Drug Administration (FDA) has granted tentative approval for its Abbrevia...